Healthcare -
Biotechnology - NASDAQ - US
$ 19.03
4.62 %
$ 14 B
Market Cap
-82.74
P/E
Price Target
Average
41.88%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
--80.99%
Net Income
Estimate
38.28%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Summit Therapeutics Inc.
Wall Street analysts predict an average 1-year price target for SMMT of $27 , with forecasts ranging from
a
low of
$8 to a high of $45 .
SMMT Lowest Price Target
Wall Street Target
8 USD
-57.96%
SMMT Average Price Target
Wall Street Target
27 USD
41.88%
SMMT Highest Price Target
Wall Street Target
45 USD
136.47%
REVENUE FORECAST
Revenue Forecast Chart SMMT
EBIT FORECAST
EBIT Forecast Chart SMMT
NET INCOME FORECAST
Net Income Chart SMMT